Public list: BIO 2016 (619) Pharma Startups (6570)
Alcobra is a pharmaceutical company committed to developing safe and effective products for the treatment of cognitive disorders including ADHD and Fragile X Syndrom.
Company (IPO / Went public)
Phone: +972 722204661
Azrieli Triangle Building 39th Floor
132 Derech Menachem Begin
6701101
Israel
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Abuse deterrent formulations of amphetamine | May 10, 2017 | Apr 03, 2018 | Patent |
Methods of treating fragile x syndrome and related disorders | Sep 09, 2014 | Dec 26, 2017 | Patent |
Methods of determining response to therapy | Sep 09, 2014 | Dec 26, 2017 | Patent |
Method for decreasing symptoms of alcohol consumption | Apr 03, 2015 | Nov 07, 2017 | Patent |
Substituted pyridoxine-lactam carboxylate-salts | Oct 03, 2014 | Aug 30, 2016 | Patent |